5:31 PM
 | 
Jan 16, 2013
 |  BC Extra  |  Financial News

Theravance planning $250M note deal

Theravance Inc. (NASDAQ:THRX) said it plans to raise $250 million through the sale of convertible subordinated notes due 2023. BofA...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >